
Pharmaceuticals · BSE
Fabino Life Sciences is engaged in the manufacturing, marketing, trading and packing of pharmaceutical and wellness-focused consumer products, with a core focus on marketing pharmaceutical formulations in the domestic market through its own distribution network and sales force under the Fabino brand, while ayurvedic formulations are produced through loan licensing arrangements and handled for packing and labeling. The company also exports wellness and FMCG products such as coffee, malt powder, protein powder and hair care products, has over 70 active products across allopathic, Covid-19, food and wellness, herbal, veterinary and multivitamin segments, markets its shampoo and hair maintenance range under the Keepshine brand, and operates a manufacturing unit in the National Capital Region of India.
Price Band
₹36
Issue Size
₹3.24 Cr
Lot Size
3000 shares
GMP
Est. Listing
₹36
at current GMP
Subscribed
—
Open
31 Dec 2021
Close
5 Jan 2022
Allotment
10 Jan 2022
Refund
11 Jan 2022
Demat Credit
12 Jan 2022
Listing
13 Jan 2022
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹36
Band: ₹36
Estimated Listing Price
₹36
Upper price + GMP
Lot Size
3000 shares
Min investment ₹1,08,000
Estimated Profit / Lot
₹0
3000 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹36 |
| 30 Oct 2026 | — | 0.0% | ₹36 |
| 29 Oct 2026 | — | 0.0% | ₹36 |
GMP is unofficial market data. Not a guarantee of listing performance.
Fabino Life Sciences Limited is bringing an initial public offering (IPO) in the Pharmaceuticals sector with an aggregate issue size of ₹3.24 Crores. The shares are offered at a price band of ₹36 to ₹36 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 3000 shares (approx. ₹1,08,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2022-01-12, while un-allotted funds or UPI block mandates will be released on 2022-01-11.
The latest grey market premium for Fabino Life Sciences Limited IPO is ₹0, which indicates an expected listing price of ₹36.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.